XPhyto Therapeutics is looking to hit a home run with their innovative medical products and therapies

New therapies and diagnostics in the pharmaceutical and medical industries can be a very lucrative area. To be successful a company has to outmaneuver the large established drug companies, or focus on niche areas. Today’s company is working on doing just that with their focus on disruptive and innovative solutions in the medical and pharmaceutical space. Two areas they are progressing rapidly are rapid COVID-19 PCR testing and psychedelics therapies for neurodegenerative and other diseases.

XPhyto Therapeutics Corp. (CSE: XPHY | OTCQB: XPHYF | FSE: 4XT) (‘XPhyto’) is a bioscience accelerator focused on next-generation drug delivery, diagnostic, and new active pharmaceutical ingredient investment opportunities. XPhyto is on the cusp of two major commercial milestones related to their rapid point-of-care COVID-19 PCR test system, with expected ISO certification and CE-IVD approval pending.

XPhyto’s Covid-ID Lab 25 minute COVID-19 PCR Test

On February 24, 2021 XPhyto announced their first order for their 25-minute COVID-19 RT-PCR tests, from their exclusive diagnostic development partner, 3a-diagnostics GmbH (‘3a’). The order was for 9,600 individual tests with delivery of the first order expected by mid-March 2021. These tests will be primarily used to supply prospective distribution partners and licensees and their respective government regulators with test samples for review and evaluation. XPhyto’s PCR test advantage over others is its rapid speed (25 minute results) and portability, as well as ease of use. They are ideal to be used for pop-up testing sites in any location. They can be done as either a nasal swab test or an oral swab test making it easy to administer.

XPhyto CEO Hugh Rogers stated:

“We are confident that Covid-ID Lab, as a 25-minute PCR test with minimal technical and personnel requirements, will be a stand-out product in the COVID-19 test market.”

If this proves to be correct we could potentially expect large product orders to start rolling in during 2021. Subject to the various regulatory approvals being successful, XPhyto expects to hold a European sales launch in April 2021. XPhyto is also currently in discussions with potential distribution and wholesale partners in Europe and the Middle East.

Assuming success in the above steps, XPhyto should be looking at potential revenues beginning in 2021.

XPhyto’s Point-of-Care rapid and portable diagnostic PCR test for COVID-19

Source

XPhyto’s psychedelics therapies for neurodegenerative diseases

On February 3, 2021 XPhyto announced a Psychedelic Pharmaceutical Production Agreement with Applied Pharmaceutical Innovation (‘Applied’) for the synthesis of pharmaceutical grade psychedelic compounds and the parallel development of the standard operating procedures necessary to obtain regulatory approval for the respective commercial production process. Applied is a not-for-profit institution at the University of Alberta created to support translational drug development for industry and innovators. This adds to XPhyto’s 2020 development agreement for the industrial production of psilocybin with a leading German university, as well as the addition of mescaline production. XPhyto plans to expand its psychedelic programs in 2021, including scalable production of pharmaceutical grade compounds, drug formulations, and clinical evaluation.

XPhyto state: “Psychedelic compounds are a highly promising new class of drugs with strong potential for the treatment of mental health related medical conditions such as depression, anxiety, addiction, and trauma-related stress disorder.” They are also said to be useful for pain management and palliative care. Psychedelics are legal in the Netherlands and recently Canada approved 17 healthcare professionals to possess and use the psychedelic active ingredient psilocybin to conduct professional training in psilocybin therapy. Data Bridge Market Research forecasts that the global psychedelics market will grow from USD 2.077B in 2019 to USD 6.859B by 2027.

Other areas for XPhyto

Also of interest is that XPhyto and 3a are developing a portfolio of oral biosensor screening tests for detection of bacterial and viral infectious diseases. Additional pandemic-focused biosensors are in development. XPhyto is planning the commercial launch of its first biosensor product in the second half of 2021. This looks to be a very exciting area with huge potential.

The other area XPhyto is active in is innovative drug delivery methods such as transdermal patches and oral dissolvable films designed for efficient and affordable delivery of approved neurological medications. Again another innovative area where there is a significant need.

Closing remarks

Innovation in the medical world can have an exponential impact on smaller companies if they have a big success. XPhyto has a reasonable chance to hit a home run – Perhaps from their leading portable 25 minute COVID-19 PCR test, from psychedelics therapies, from their oral biosensor products or from their innovative drug delivery products.

XPhyto Therapeutics Corp. certainly has a lot going on and trades on a market cap of C$171M.




Red Light Holland rides the wave of growth in the relatively new psychedelics industry

The psychedelics industry is just starting to grow now from a small base and looks quite likely to follow in the footsteps of the cannabis industry’s recent success story. Data Bridge Market Research forecasts that the global psychedelics market will grow from USD 2.077B in 2019 to USD 6.859B by 2027. Looking at these numbers that’s a 3.3 times increase in just 7 years. Growing acceptance of psychedelic drugs for treating depression and mental disorders are key factors for the forecast growth.

Psychedelics are the class of hallucinogenic drugs that may be used recreationally or for medical purposes. Their main benefits are in enhancing the sensory perception, elevating mood, and promoting spiritual experiences. Psychedelic drugs can be used in a medical setting to help depression, psychological treatments, palliative care and as an aid to help control the mind to be calm and peaceful.

Psychedelics are legal in the Netherlands, where there an estimated 100 Smart Shops operating, generating over US$100 million in sales annually. The price for 10 grams of truffles (the maximum amount for a beginner) is between 10 to 15 Euros in Amsterdam. Just recently Canada approved 17 healthcare professionals to possess and use the psychedelic active ingredient psilocybin to conduct professional training in psilocybin therapy. The focus is mainly for patients dealing with end-of-life distress, but marks the first step towards legal medicinal psychedelics use in Canada.

Red Light Holland Corp. (CSE: TRIP) is a leader in this market and is well advanced to benefit from the forecast very strong growth. They recently began selling their premium ‘magic truffles’ products (psychedelics) in the Netherlands. The Netherlands has a long-standing, established legal magic truffles market. Red Light Holland is currently setting up to further grow, distribute and market a premium brand of magic truffles to the legal recreational market within the Netherlands. They are also focusing on the medicinal side of the psychedelics industry as well as expanding their global sales to legal destinations.

Red Light Holland’s business plan is to produce and sell recreational and medical grade truffle products (psychedelics) in legal markets starting in the Netherlands

Source: Company website

Red Light Holland has recently raised over C$20M, providing the Company with over C$30M in the bank, this includes the latest C$11.6M bought deal financing. The funds intend to be used for working capital and general corporate purposes, essentially to grow the business. Red Light Holland has already grown and pre-sold their first batch of magic truffles from their production facility in Horst, Netherlands. They are now growing a further 1,000,000 grams of magic truffles. CEO Todd Shapiro stated: “Red Light Holland is ecstatic to announce that we have started to grow our second batch of magic truffles, expected to be 10X the original batch’s size.”

Global and product expansion potential for Red Light Holland

On February 25, 2021, Red Light Holland announced: “iMicrodose pack receives authorization for the first legal import and sale of psilocybin truffles to Brazil…..for prescribed medical patient use.” The iMicrodose pack contains 15g of psilocybin truffles made by Red Light Holland. This marks a significant milestone for Red Light Holland with their “first prescribed by a physician for medical use” of their truffles product, as well as an advancement in opening up the legal and medically approved market for psilocybin in Brazil.

On December 30, 2020, Red Light Holland announced they intend to make a groundbreaking investment in the St. Vincent and the Grenadines’ plant-based wellness and psychedelics industry, via a purchase of 100% of Mera Life Sciences LLC (‘Mera’). St. Vincent and the Grenadines are islands in the Caribbean Sea. Mera is developing a modern medicinal industry in St Vincent and the Grenadines with their issued psychedelic licenses. Todd Shapiro, CEO and Director of Red Light Holland, stated: “The acquisition of Mera and its coveted licenses would allow Red Light Holland to perform high quality psychedelic product research and development, cultivate, extract and process, and export, not just Psilocybin, but with compounds such as Ayahuasca, MDMA, DMT, Peyote, Ketamine and many other natural based plants as well…..”

On December 20, 2020, Red Light Holland announced it has entered into a non-binding letter of intent to acquire 51% of Psychedelic Insights in Amsterdam, the Netherlands. Psychedelic Insights currently provides psychedelic assistance to clients from all over the world, who are in need and want to try a safe and psychological guided experience. This includes psychedelic palliative care, re-connecting veterans and global mental health screening. A condition in the agreement includes an exclusive supply agreement with Red Light Holland’s truffles, grown from Red Light Holland’s facility in Horst, Netherlands.

Closing remarks

Red Light Holland continues to ride a wave of success with their magic truffles psychedelics. A 10x increase in their truffle production following the first batch being 100% pre-sold in advance, an overseas expansion potential via 100% acquisition with Mera, a potential 51% Psychedelic Insights acquisition (global client base), and finally, some initial success selling into Brazil. Added to all this it appears the medicinal use of psychedelics is making progress in Canada.

It certainly looks like Red Light Holland will continue to rapidly grow, especially after their successful capital raises and now C$30M in the bank. Red Light Holland’s market cap has dramatically increased as a result of all this good news and now sits at C$134M. Exciting times ahead, both for the Company and the industry.




Can Psychedelics Follow Cannabis’ Lead?

Greenlight for Red Light Holland as Distribution Agreements Grow

Red Light Holland Corp. (CSE: TRIP) (“RLH”) engages in the production, growth, and sale of a premium brand of magic/hallucinogenic truffles to the recreational market in the Netherlands.

The Company is pre-revenue, with lots of potential, as it builds out a custom, 3000 square foot growing facility in Horst, the Netherlands.

To generate some immediate revenue and build its brand, the Company procured 10,000 units of psychedelic truffles for re-sale and started selling its Microdosing Packs of magic truffles in September through existing Smart Shop operators and its e-commerce platform. Its Microdosing Pack contains a small amount of magic truffle promoting responsible use, with the drug benefits but without the intensity of a full psychoactive experience.

Distributions Deals

In September, RLH signed a distribution agreement for its Microdosing Packs with Super Smart’s location in Tiel, the Netherlands.

Then in October, the Company reached a distribution arrangement with Smartshop Oss, in Oss, the Netherlands.

Finally, RLH completed a distribution arrangement with 3 House of Smart locations in the Netherlands, located in the cities of Rotterdam, Eindhoven and Den Bosch.

Todd Shapiro, CEO of RLH, commented, “clearly we are excited for a broad and diverse adult demographic, within all of these beautiful areas, to soon have the opportunity to see our brand and potentially purchase our responsible-use product.”

Psychedelics Industry

The psychedelics industry is similar to where the cannabis industry was 10 years ago as it fights for legalization in various countries. The use of psychedelic products is currently illegal in most jurisdictions, however countries such as the Netherlands and Jamaica have legalized some forms of psychedelics.

Psilocybin is the chemical alkaloid that induces psychedelic effects, often found in psilocybin mushrooms (“magic mushrooms”) or psilocybin truffles (“magic truffles”).

RLH is currently growing 3 different strains of magic truffles: Psilocybe Mexicana, Psilocybe Galindoi, and Psilocybe Tampanensis, and expects to have an initial batch of 100,000 grams of magic truffles available this quarter.

Retail establishments in the Netherlands that specializes in the sale of psychoactive substances, such as magic truffles, are called Smart Shops. There are an estimated 100 Smart Shops operating in the Netherlands, generating over US$100 million in sales annually.

New Clinical Market

The psychedelics industry has since gained some traction with pharmaceutical companies starting to research the effects of psychedelics on a range of medical ailments from mental health to cancer.

In September, RLH announced that its science division, Scarlette Lillie Science and Innovation, entered into a relationship with Jinfiniti Precision Medicine in order to explore the potential roles that psilocybin and magic truffles can play for age-related and psychiatric disorders.

Jinfiniti has created a blood test that can detect key factors that drive aging and other genetic instabilities. Jinfiniti’s fast and low cost test allows for scientists from both companies to clearly evaluate the potential for psilocybin treatments that go beyond what is currently being explored.

The relationship with Jinfiniti opens up a whole new clinical market that goes beyond the recreational market.

High Profile Management Team

RLH has several prominent management executives and celebrities to help drive its growth and brand recognition, including: Ann Barnes, co-founder of Peace Naturals; Bruce Linton, founder and former CEO of Canopy Growth; Tony Clement, the former Health Minister of Canada (2006-2008); and, Russell Peters, a comedian with international brand recognition and over 5.5 million people on his social media platforms.

Funded for Growth

The Company had $6.6 million in cash as of June 30, 2020, after raising over $4 million in private placement in June.

RLH is currently trading at $0.08 with a market cap of only $17.2 million has plenty of room for upside gains.

iMicrodose Pack of Magic Truffles by Red Light Holland

iMicrosdose Pack - Red Light Holland

Source




Red Light Holland enters the market of legal magic truffles

Exploring the recreational and potential medical use of psychedelics

Most people have heard of ‘magic mushrooms’, but they may be unfamiliar with their fungi cousin magic truffles. Magic truffles are legal and very popular in the Netherlands and are well known for their hallucinegic properties that result in psychedelic effects. What is less well known is that truffles have a number of potential health benefits related to reducing anxiety and depression, lifting mood, and freeing the mind. The price for 10 grams of truffles (the maximum recommended dose for a beginner) is between 10 to 15 Euro in Amsterdam.

Red Light Holland Corp. (CSE: TRIP | FSE:4YX) (“RLH”) is in the ‘magic truffle’ business. The Company aims to engage in the production, growth and sale of a premium brand of magic truffles to the legal, recreational market within the Netherlands. Their business revolves around a premium brand of magic truffles. Sales are conducted through existing Dutch Smartshops storefront operators and an advanced e-commerce platform. The Netherlands is a country with a long-standing, established, legal magic truffles market.

Red Light Holland is now starting to commercialize their premium magic truffles in the Netherlands for both recreational and eventual medicinal use

Source: Company presentation

In some surprising news in August, RLH announced that it had commenced its “magic truffles growth operation in the Netherlands, months ahead of schedule…” Red Light Holland has “expedited the build out of its approximately 3,000 square feet, custom built, indoor growing, production and distribution facility of the Company, in Horst, the Netherlands (the “Facility“) and has commenced growing its first crop of magic truffles.”

RLH has also ordered 10,000 units of Psychedelic Truffles Microdosing Packs from McSmart (one of the Netherlands’ prominent truffle growers, distributors and Smart Shop owners), to launch the Microdosing Packs within the Netherlands as early as September 2020. RLH plans to sell these via three Smart Shops operated by McSmart, as well as through Red Light Holland’s proposed e-commerce platform and McSmart’s existing e-commerce platform.

Red Light Holland has also been on a hiring spree adding 7 new high-level members to their team with a wide variety of both business and medical (psychedelics) knowledge and experience. One of the new hires, Sarah Hashkes from RadixMotion, will focus on developing an innovative virtual reality shopping experience (VR Module, due by Q4 2020) for Dutch Smart Shops and e-commerce platforms. Sarah Hashkes is the CEO of RadixMotion and a scientific researcher with knowledge on microdosing and is RLH’s new Scientific Advisor. Part of her mandate is to educate the public about psilocybin, the active ingredient in magic truffles.

The project also includes having a “VR Avatar”, expected to be online by Q3 2020. The VR Avatar is expected to assist Red Light Holland’s larger efforts towards reducing the stigma associated with magic truffles and other psychedelic substances. The Avatar, RLH explains, is to help the novice: “Now imagine shopping for something new – but wanting to truly experience it before purchasing? Pretty cool idea, right? What we are aiming to create here is a virtual reality experience that potential consumers can use before buying our Microdose Packs. This way, they can experience what the effects of microdosing magic truffles would be like, to help with their personal comfort and understanding before actually purchasing our product.”

Sounds rather cool to me. I think it will be quite popular for the curious to try this out. What do readers think?

Red Light Holland is currently growing three different strains of magic truffles and expects to have an initial batch of approximately 100,000 grams of magic truffles available in late October, 2020.

Red Light Holland carves out a unique market niche

Source: Company presentation

Closing remarks

Red Light Holland is moving surprisingly fast to commercialize and promote their product range of premium magic truffles. Considering the Company only listed in Canada this year in late May, then in Germany in June, it is quite amazing that operations have already begun and they are already producing their own magic truffles.

Red Light Holland trades on a market cap of just C$19m as investors are yet to learn about the Company, and their large potential to rapidly expand and create revenues in the lucrative magic truffles market in the Netherlands. Exciting times are ahead for Red Light Holland with a new innovative VR Avatar virtual reality shopping experience, with sales and revenues all not that far away in Q3 and Q4 of this year.




InvestorIntel Announces Partnership with InvestorChannel for Daily Distribution of Data Driven Market Watchlists

Leading investor source, market sector leaders and market experts unite to provide investors with daily market updates via social media outlets

Toronto, August 13, 2020 — InvestorIntel.com, a leading online source of investor information, is pleased to announce its partnership with InvestorChannel.com, a daily data-driven market sector update system that is all video.

“Every time the headlines discuss Chinese-US tensions, investors call me and ask me to send them a list of rare earths’ companies trading in the public markets,” said Tracy Weslosky, founder of InvestorIntel.com and co-founder of InvestorChannel.com. “For example, gold breaks $2,000, or a new Esports CEO does a riveting interview on the increasing audience and revenue for online gaming, and my email inbox fills with the same questions from investors. So, I called Moovly Media Inc. (TSXV: MVY) CEO and co-Founder Brendon Grunewald in Brussels and said – help me. Help me figure out a way to tweet out a compliant-friendly update on the sectors that are fun to watch and helps me share the list of the sector-leading public companies we at InvestorIntel follow and get an idea of how they are really doing.”

InvestorChannel.com provides both novice and professional investors with timely information to shape their decision-making. “After all,” she continued, “the conventional investor media told me every single day that I couldn’t lose if I bought cannabis or crypto stocks last year, but if I had a tool that actually compared how 20 or so companies were actually faring – I could get a real handle on what’s really happening, instead of having to rely on what people are telling me is going on.”

Moovly Media CEO Brendon Grunewald has a vision for InvestorChannel.com: “I thought we would take things up a notch by using the market leading video automation technology of Moovly Media and combining it with intelligently designed software to grab data from a range of both proprietary and publicly available data sources. We can use that to produce interesting market updates, such as the top gainers on an exchange for the day or best performing companies in a specific sector. The result is a platform that is designed to produce an ever-growing amount of insightful content in the most effective online communication medium, Video.

In addition to a US, CDN, UK and Hong Kong Markets update watchlist, there are also a dozen sponsored watchlists that run daily on InvestorChannel:

About InvestorIntel.com
InvestorIntel.com is a leading online source of investor information that provides public market coverage for both investors and industry alike. Offering coverage of emerging markets and investment opportunities to discerning investors, InvestorIntel is considered an online influencer in analysis, videos and podcast reports and hosts Investor Talks for self-directed investors online.

About InvestorChannel.com
InvestorChannel.com is a data-driven fintech company that is focused on using the latest in artificial intelligence (AI) and other analytics technologies to develop a platform that produces timely, insights into companies and industries listed on the capital markets. Updates are published in video and disseminated via a variety of online channels through partner InvestorIntel.com. Updates are published on an InvestorChannel YouTube channel (click here to subscribe) and automatically tweeted out daily through @TracyWeslosky.

For more information on either InvestorIntel or InvestorChannel, email Tracy Weslosky at tracy@investorchannel.com or contact us direct at +1 416 792 8228.




MI3 Tech Note on Red Light Holland Corp. (CSE: TRIP)

Mario Drolet President of MI3 Communications Financières Inc. (MI3) released a technical note at market open today on Red Light Holland Corp. (CSE: TRIP) for exclusive distribution on InvestorIntel. In this note, MI3 highlighted the following points on Red Light Holland Corp.:

  • The Company is an Ontario-based corporation positioning itself to engage in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles to the legal, recreational market within the Netherlands, in accordance with the highest standards, in compliance with all applicable laws.
  • Strong Management team and Advisory members.
  • Bruce Linton is the Chairman of TRIP … ex-Canopy Growth CEO
  • TRIP traded over 140 Million shares since May between $0.095 & $0.25
  • Support: S2; $0.08    S1; $0.10   Resistance:   R1; $0.14    R2; $0.16

About Red Light Holland Corp.

The Company is an Ontario-based corporation positioning itself to engage in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles to the legal, recreational market within the Netherlands, in accordance with the highest standards, in compliance with all applicable laws.

PLEASE DO YOUR DUE DILIGENCE

Disclaimer: This MI3 Technical Note produced by MI³ Communications Financières is neither an offer to sell, nor the solicitation of an offer to buy any of the securities discussed therein. The information contained is prepared by MI3, emanating from sources deemed to be reliable. MI3 Communications Financières makes no representations or warranties with respect to the accuracy, correctness or completeness of such information. MI³ Communications Financières accepts no liability whatsoever for any loss arising from the use of the information contained therein. Please take note that for compliance purposes, all directors, consultants or employees of MI3 Communications Financières are prohibited from trading the securities of the company and MI3 Communications Financières is a shareholder and do not intend to sell any shares during the distribution of this note.




How Lucky prepared us for COVID-19, and introducing the Investor Talks Series

A good friend of mine always reminds me that the real secret to business success is to always start by identifying the pain points and then, offer a solution. COVID-19 offered multiplicitous challenges for our clients this year from unprecedented social media harassment to standstill sales. We, like many others have been quietly watching and assessing patterns brought forth from the pandemic with the clear understanding that this is not over.

Surprised by some of the surging stock prices of some of our star performers (charts below), from Exro Technologies Inc. (CSE: XRO | OTCQB: EXROF) to Predictmedix Inc. (CSE: PMED | OTCQB: PMEDF), I guess we thought our market would be as compromised as our social schedule?

None of us could predict anything.

The illustrious COVID-19 Pandora’s Box that braised us all has been kinder on us than most because of our interest in the critical materials sector. Rolling out the Technology Metals Show with Jack Lifton a month ago and having interviewed everyone from Constantine Karayannopoulos to Randy Scott, Jack’s commentary resonated with audiences with a formula that anyone could have predicted — dependency that is off-balance with others makes one weak.

Then…

Investing in technology and inspired by who would win the COVID-19 race in the marketplace, we started InvestorChannel.com and rolled out a COVID-19 Stock Watchlist. Another predictable formula was that whomever came across the finish line with a vaccination was going to clearly be the stock to have invested in. Following the Top 20 capital markets companies as identified by the Milken Institute, we thought — wow, this watchlist is really cool, what else can we do…

So, we did.

We started with an InvestorChannel Gold Watchlist, sponsored by our friends at Quebec Precious Metals Corp. (TSXV: CJC | OTCBB: CJCGG), we identified 20 gold companies we were interested in and created a Top 5 Performer list. Daily updates rolled out at market close, published on InvestorChannel.com, we then programmed these 2 Watchlists to go live on InvestorIntel.com at market close daily.

Then, we built the daily Canadian Market Watchlist, the US Market Watchlist and then started with sectors we loved next…

We rolled out a Uranium Market Watchlist, which Fission Uranium Corp. (TSX: FCU | OTCQX: FCUUF) graciously sponsored. Again, live on the InvestorChannel.com, then published and distributed on InvestorIntel.com and then tweeted out through @InvestorChanel, @Investor_Intel and as often as I could personally via @TracyWeslosky. Allow us to thank everyone who follows us, we follow you back!

And of course, we could not do this without a Rare Earths Watchlist, rising leader in the critical materials sector Energy Fuels Inc. (NYSE American: UUUU | TSX: EFR) stepped in. We have enjoyed their webcasts during this crisis.

So, what now?

Flashback: In 2001 we were on Bay Street before we moved to Richmond Street West where we would be headquartered for more than a decade. We moved out of the King Edward office 2 years ago, then tried a loft on Sumach – the idea was simple. A cool trendy 2600+ square feet in the ole CBC Production studios to bring in clients, hang out and drink coffee. The idea was an esports center where we could film interviews, no one was prepared for the critical downfall of this plan…no one liked my cat.

Apparently quite a few people are allergic to cats. Watching several people dance around hopping from foot to foot and declaring that they would be covered in hives if the cat was not removed instantly! With this, my grey fuzzy cat named Lucky with the big green eyes had created a do or die situation for me… it was either move him countryside and only seem him on weekends or move my office.

We moved the studio and by mid-February, we were fully functional in our homes. Looking back – I guess we have Lucky the Cat to credit for preparing us for this pandemic.

Now withstanding the many real issues, we are contending with like everyone over COVID-19’s challenges to our business, the coronavirus has not been without many positives for our team. Inspiring creativity– expect numerous news releases in the next quarter, this has been the catalyst for collaborations.

And this was not without input from our amazing audience —  with texts, tweets and emails that included: “can you coordinate presentations online?”, “have you cancelled your 8th Annual Technology Metals Summit, are you doing it online?” or “when is your next ii6 and are you doing this online?”

And here was our thought…we did not know what to do, so we waited.

We watched others do online virtual conferences and we asked for feedback from both audience and presenters. Online events are boring said some. I mean without the interactive component, the occasional heckling, the debate – interest we can see is already subsiding. After all, it’s just a talking head without the fun of people coming together.

So, we decided to try something different. While online presentations are indeed a necessary evil, we asked ourselves how we could do make this interactive and as close to as a social experience while allowing us to drink coffee and take notes…

Drum roll…

Would you like to engage with 4-5 relatively interesting peers in a 25-30 minute webcast where instead of you hitting mute while you continue your binge watching of Netflix in the background while they flip through 40+ pages of slides (we ask companies to limit slide decks to 15-18) and have a real discussion with the CEO of one of a potentially rising market stars? Discuss with your peers what is really happening in their sector and have a real heart to heart on the merits of their business model?

It gets better…

While I love Zoom and Skype for different reasons, we have opted to utilize Moovly Media Inc.’s (TSXV: MVY) MVC system. No downloading of anything, you just hit our confidential link and ‘bam’ your live and at the event – in a matter of seconds.

Sending out the 1st invitations to our private list later today for one on Wednesday for a stock that has doubled since March 24th and one of the most talked about psychedelics companies that just recently listed on Thursday. If you would like to join the InvestorIntel Special Report Alert, click here and will ensure that you are invited!

Simple, inspiring and even fun, join 4-5 fellow investors or industry leaders in an interactive presentation experience, we now affectionately refer to as Investor Talks.